Pulmonary delivery of liposomes co-loaded with SN38 prodrug and curcumin for the treatment of lung cancer

被引:17
|
作者
Gao, Chengzhi [1 ]
Zhang, Lanfang [2 ]
Xu, Minhao [1 ]
Luo, Yi [1 ]
Wang, Ben [1 ]
Kuang, Meiyan [1 ]
Liu, Xingyou [1 ]
Sun, Meng [1 ]
Guo, Yue [1 ]
Teng, Lesheng [3 ]
Wang, Chenhui [2 ]
Zhang, Yan [2 ]
Xie, Jing [1 ]
机构
[1] Chongqing Univ Technol, Sch Pharm & Bioengn, 69 Hongguang Rd, Chongqing 400054, Peoples R China
[2] Chongqing Univ, Innovat Drug Res Ctr, Sch Pharmaceut Sci, Chongqing Key Lab Nat Prod Synth & Drug Res, 55 South Daxuecheng Rd, Chongqing 401331, Peoples R China
[3] Jilin Univ, Sch Life Sci, 2699 Qianjin Rd, Changchun 130012, Peoples R China
关键词
Pulmonary delivery; SN38; Curcumin; Lung cancer; MICROFLUIDIC SYNTHESIS; NANOPARTICLES; DOXORUBICIN; ACID;
D O I
10.1016/j.ejpb.2022.08.021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A co-delivery system of SN38 (7-ethyl-10-hydroxyl camptothecin) prodrug and CUR (curcumin) was designed for the treatment of lung cancer by pulmonary delivery. SN38 was linked to cell-penetrating peptide (CPP) TAT via a polyethylene glycol (PEG) linker to form the SN38 prodrug (TAT-PEG-SN38). Liposomes co-loaded with amphiphilic TAT-PEG-SN38 and curcumin (Lip-TAT-PEG-SN38/CUR) were successfully prepared by a micro -fluidic method for the treatment of lung cancer via pulmonary delivery. Lip-TAT-PEG-SN38/CUR showed nanometer-sized sphericity and a particle size of 171.21 nm. Besides, Lip-TAT-PEG-SN38/CUR exhibited enhanced antiproliferative effect, increased cell apoptosis induction and improved cell cycle arrest compared to the single agents in vitro. The combination induced significant tumor inhibition in a BALB/c mouse lung cancer model. These results indicated that our SN38 prodrug and curcumin co-delivery system was a promising candidate for lung cancer treatment.
引用
收藏
页码:156 / 165
页数:10
相关论文
共 50 条
  • [21] Self-amplifying ROS-responsive SN38 prodrug nanoparticles for combined chemotherapy and ferroptosis in cancer treatment
    Qin, Yu
    Liu, Na
    Wang, Fenghui
    Gao, Zeping
    Luo, Cong
    Tian, Chutong
    Kamei, Ken-ichiro
    CARBON, 2025, 235
  • [22] Targeted Ultrafine Iron Oxide Nanoparticles for Delivery of the Topoisomerase Inhibitor SN38 and Ovarian Cancer Treatment
    Liu, Nianyuan
    Lai, Lanjin
    Xu, Peijia
    Padelford, Jonathan
    Xue, Ting
    Zhang, Hua
    Zhu, Xingkai
    Xue, Xingkui
    Wang, Liya
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2022, 18 (07) : 1738 - 1745
  • [23] RETRACTION: EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer
    Burande, Ankita Sanjay
    Viswanadh, Matte Kasi
    Jha, Abhishek
    Mehata, Abhishesh Kumar
    Shaik, Azad
    Agrawal, Nishi
    Poddar, Suruchi
    Mahto, Sanjeev Kumar
    Muthu, Madaswamy S.
    AAPS PHARMSCITECH, 2024, 25 (06):
  • [24] Ceramide-Fabricated Co-Loaded Liposomes for the Synergistic Treatment of Hepatocellular Carcinoma
    Yin, Xiaolan
    Xiao, Yanan
    Han, Leiqiang
    Zhang, Bo
    Wang, Tianqi
    Su, Zhihui
    Zhang, Na
    AAPS PHARMSCITECH, 2018, 19 (05): : 2133 - 2143
  • [25] Ceramide-Fabricated Co-Loaded Liposomes for the Synergistic Treatment of Hepatocellular Carcinoma
    Xiaolan Yin
    Yanan Xiao
    Leiqiang Han
    Bo Zhang
    Tianqi Wang
    Zhihui Su
    Na Zhang
    AAPS PharmSciTech, 2018, 19 : 2133 - 2143
  • [26] Co-delivery liposomes of irinotecan hydrochloride and curcumin in the synergistic treatment of colorectal cancer
    He, Suping
    Wang, Yanxia
    Qi, Jianhong
    Chen, Huan
    Zhou, Wei
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 98
  • [27] Efficient transfected liposomes co-loaded with pNrf2 and pirfenidone improves safe delivery for enhanced pulmonary fibrosis reversion
    Chang, Xin
    Liu, Chang
    Han, Yu-Mo
    Li, Qiu-Ling
    Guo, Bin
    Jiang, Hu-Lin
    MOLECULAR THERAPY NUCLEIC ACIDS, 2023, 32 : 415 - 431
  • [28] Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy
    Zhang, Bo
    Wang, Tianqi
    Yang, Shaomei
    Xiao, Yanan
    Song, Yunmei
    Zhang, Na
    Garg, Sanjay
    JOURNAL OF CONTROLLED RELEASE, 2016, 238 : 10 - 21
  • [29] Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation
    Jiang, Kanqiu
    Shen, Mingjing
    Xu, Weihua
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018, 13 : 2561 - 2569
  • [30] Nanoscale Liposomes Co-Loaded with Irinotecan Hydrochloride and Thalidomide for Colorectal Cancer Synergistic Therapy
    Sun, Xuanrong
    Gong, Yubei
    Xie, Ting
    Fu, Zixi
    Lu, Dongze
    Wei, Bin
    Cai, Yue
    Yao, Wenlong
    Shen, Jie
    MACROMOLECULAR BIOSCIENCE, 2024,